[ad_1] One of the most valuable private companies in the biotechnology sector has finally gone public. Moderna Therapeutics, a company developing messenger RNA-based treatments, achieved a $ 7 billion private valuation. On …
Read More »Stephen Hoge, president of Moderna, reveals compensation in filing his initial public offering for savings
